The Next Cancer Drug Might Start in Outer Space

Shou-Ching Jaminet, a molecular biologist and former researcher at Harvard Medical School, spent almost a year preparing an experiment for her small biotech startup, Angiex, to study the effects of weightlessness on a potential cancer drug. By June she was nervous with anticipation, readying her project for launch on an International Space Station resupply mission powered by a SpaceX Falcon 9. But before it blasted off, she wanted to lay eyes on a dolphin. In rocketry, she’d been told, it’s good luck to see one (and bad luck to see a pig) prior to liftoff. So the night before ...